intraoperative cisplatin
Showing 1 - 25 of 5,716
Mesothelioma Trial (Magnesium sulfate, Normal Saline)
Not yet recruiting
- Mesothelioma
- Magnesium sulfate
- Normal Saline
- (no location specified)
Feb 15, 2023
Oral Squamous Cell Carcinoma Trial (PRV211 (Intraoperative Cisplatin System))
Not yet recruiting
- Oral Squamous Cell Carcinoma
- PRV211 (Intraoperative Cisplatin System)
- (no location specified)
May 30, 2023
Mesothelioma Trial in Boston (Magnesium Sulfate)
Completed
- Mesothelioma
- Magnesium Sulfate
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 10, 2022
Ovarian Cancer Recurrent Trial in Uppsala (radical surgery with HIPEC)
Recruiting
- Ovarian Cancer Recurrent
- radical surgery with HIPEC
-
Uppsala, SwedenUppsala University Hopsital
Oct 1, 2021
Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)
Not yet recruiting
- Epithelial Ovarian Cancer
- Acute Kidney Injury Due to Circulatory Failure
- Sodium Sulfate
- +2 more
- (no location specified)
May 17, 2023
Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemo, Hydration Trial in Beijing (Urine-guided hydration, Routine
Not yet recruiting
- Cytoreductive Surgery
- +5 more
- Urine-guided hydration
- +3 more
-
Beijing, ChinaAerospace Center Hospital
Jul 11, 2023
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- 5-Fluorouracil
- +4 more
-
Aachen, Germany
- +14 more
Sep 7, 2022
Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)
Recruiting
- Gastric Cancer
- +3 more
- Indocyanine green
-
Montréal, Quebec, Canada
- +1 more
Jan 8, 2023
Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)
Completed
- Bladder Cancer
- induction cisplatin
- +13 more
-
Atlanta, Georgia
- +10 more
May 23, 2022
Head Neck Cancer Trial in Columbus (drug, radiation, procedure)
Terminated
- Head and Neck Cancer
- Cisplatin
- +3 more
-
Columbus, OhioOhio State University Medical Center
Oct 29, 2021
Seminoma Trial in Duesseldorf (Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of
Recruiting
- Seminoma
- Robot-assisted retroperitoneal lymph node dissection
- Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
-
Duesseldorf, GermanyUniversity Hospital of Duesseldorf
Nov 17, 2023
Recurrent Ovarian Cancer Trial in Bochum (chemo with doxorubicin and cisplatin)
Completed
- Recurrent Ovarian Cancer
- chemotherapy with doxorubicin and cisplatin
-
Bochum, NRW, GermanyRuhr University Bochum
Jul 7, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Tumor in the Peritoneum Trial in
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Biospecimen Collection
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 2, 2023
Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)
Recruiting
- Malignant Pleural Mesothelioma
- Chemotherapy Effect
- hyperthermic intrathoracic chemotherapy
-
Cairo, EgyptAin Shams University hospitals
Aug 18, 2022
Ovarian Cancer, Primary Peritoneal Cancer Trial in Ghent (Cytoreductive surgery, IPEC with Cisplatin (75mg/m²), IPEC with
Unknown status
- Ovarian Cancer
- Primary Peritoneal Cancer
- Cytoreductive surgery
- +4 more
-
Ghent, East-Flanders, BelgiumUZ Ghent
Jan 14, 2019
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Neoadjuvant Therapy
- 3cycles (Toripalimab + cetuximab)
- +2 more
-
Wuhan, Hebei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Neoadjuvent
- +3 more
- Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
-
Xi'an, Shaanxi, China
- +2 more
Aug 17, 2023
Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,
Active, not recruiting
- Disseminated Neuroblastoma
- +5 more
- cyclophosphamide
- +18 more
-
Birmingham, Alabama
- +22 more
Mar 3, 2022
Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-,
Completed
- Cholelithiasis, Common Bile Duct
- endoscopic retrograde cholangiopancreatography
-
Linz, AustriaKepler University Hosital Linz
Nov 8, 2023
Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)
Recruiting
- Ototoxicity, Drug-Induced
- Sodium Thiosulfate
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 6, 2023
Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)
Active, not recruiting
- Drug Toxicity
-
Rawalpindi, Punjab, PakistanMedical Oncology department, Fauji Foundation Hospital
Aug 25, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),
Not yet recruiting
- Locally Advanced Unresectable Esophageal Squamous Carcinoma
- Docetaxel for Injection (Albumin-bound)
- +4 more
-
Jinan, Shandong, China
- +1 more
Nov 16, 2023
Scoliosis Trial in Seoul (Tranexamic acid, Tranexamic acid infusion under ROTEM-guidance)
Recruiting
- Scoliosis
- Tranexamic acid
- Tranexamic acid infusion under ROTEM-guidance
-
Seoul, Korea, Republic ofSeoul national university hospital
Oct 13, 2023